EG
Eagle Pharmaceuticals, Inc.
EGRX · OTC
$0.18 +11.59% (+$0.02)
1M +143.40%
Piotroski F-Score Moderate
4/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Current ratio N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
100 /100
Stable Beta 0.66x
EPS volatility N/A
Profitable years N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about EGRX
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Michael Graves
Employees
135
Headquarters
Woodcliff Lake
Upcoming events
09 NOV
Earnings
Upcoming earnings report